# Bimatoprost in the Treatment of Eyelash Hypotrichosis

> **NCT01698554** · PHASE3 · COMPLETED · sponsor: **Allergan** · enrollment: 464 (actual)

## Conditions studied

- Idiopathic Eyelash Hypotrichosis

## Interventions

- **DRUG:** bimatoprost formulation A solution
- **DRUG:** bimatoprost solution 0.03 %
- **DRUG:** vehicle of bimatoprost formulation A solution
- **DRUG:** vehicle of bimatoprost solution 0.03 %

## Key facts

- **NCT ID:** NCT01698554
- **Lead sponsor:** Allergan
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-11
- **Primary completion:** 2014-02
- **Final completion:** 2014-03
- **Target enrollment:** 464 (ACTUAL)
- **Last updated:** 2015-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01698554

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01698554, "Bimatoprost in the Treatment of Eyelash Hypotrichosis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01698554. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*